[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$fB6Be2DjTZNH8W7l_qZURVUkV8aitafnhfegPhlqSUtw":3},{"sponsor":4,"sponsorVariants":5,"totalTrials":6,"truncated":7,"activeTrials":8,"phase3Count":9,"totalEnrollment":10,"activePrograms":11,"nonDrugCount":12,"topConditions":13,"upcomingReadouts":31,"phaseBuckets":42,"rows":49},"Albany Medical College",[4],79,false,11,4,9904,2,47,[14,16,19,21,23,25,27,29],{"name":15,"count":9},"Patent Ductus Arteriosus",{"name":17,"count":18},"Chronic Pain",3,{"name":20,"count":18},"Neuropathic Pain",{"name":22,"count":18},"Prostate Cancer",{"name":24,"count":11},"Obesity",{"name":26,"count":11},"Preeclampsia With Severe Features",{"name":28,"count":11},"Pain, Postoperative",{"name":30,"count":11},"Failed Back Surgery Syndrome",[32,37],{"nctId":33,"briefTitle":34,"date":35,"intervention":36},"NCT04312880","Tranexamic Acid Infusion During Elective Spine Surgery","2021-01-01","Tranexamic Acid",{"nctId":38,"briefTitle":39,"date":40,"intervention":41},"NCT05629494","Anti-inflammatory Drugs and Serum Prostate-Specific Antigen Test","2026-03-01","Ibuprofen 400 mg, TID",[43,44,45,46,47,48],"EARLY_PHASE1","PHASE1","PHASE2","PHASE3","PHASE4","NA",[50,86,110,137,163,190,208,233,251,276,301,319,344,370,392,418,436,463,481,507,533,551,576,594,620,645,671,689,714,739,762,788,806,832,850,875,893,926,951,974,1000],{"intervention":36,"totalTrials":11,"cells":51},{"EARLY_PHASE1":52,"PHASE1":55,"PHASE2":57,"PHASE3":59,"PHASE4":61,"NA":84},{"trials":53,"activeCount":54},[],0,{"trials":56,"activeCount":54},[],{"trials":58,"activeCount":54},[],{"trials":60,"activeCount":54},[],{"trials":62,"activeCount":83,"soonestReadout":35},[63,75],{"nctId":64,"briefTitle":65,"status":66,"phases":67,"primaryCompletion":68,"completion":69,"start":70,"enrollment":71,"conditions":72,"interventions":74},"NCT03359525","Study Comparing Topical Versus Intravenous Tranexamic Acid in Anterior Total Hip Arthroplasty","UNKNOWN",[47],"2019-06-30","2019-12-31","2017-07-01",114,[73],"Tranexamic Acid Adverse Reaction",[36],{"nctId":33,"briefTitle":34,"status":76,"phases":77,"primaryCompletion":35,"completion":35,"start":78,"enrollment":79,"conditions":80,"interventions":82},"ENROLLING_BY_INVITATION",[47],"2018-12-01",65,[81],"Spine Surgery",[36],1,{"trials":85,"activeCount":54},[],{"intervention":41,"totalTrials":83,"cells":87},{"EARLY_PHASE1":88,"PHASE1":90,"PHASE2":92,"PHASE3":94,"PHASE4":96,"NA":108},{"trials":89,"activeCount":54},[],{"trials":91,"activeCount":54},[],{"trials":93,"activeCount":54},[],{"trials":95,"activeCount":54},[],{"trials":97,"activeCount":83,"soonestReadout":40},[98],{"nctId":38,"briefTitle":39,"status":99,"phases":100,"primaryCompletion":40,"completion":101,"start":102,"enrollment":103,"conditions":104,"interventions":107},"RECRUITING",[47],"2026-12-01","2022-09-27",198,[22,105,106],"Prostate Inflammation","PSA",[41],{"trials":109,"activeCount":54},[],{"intervention":111,"totalTrials":83,"cells":112},"Galcanezumab-Gnlm",{"EARLY_PHASE1":113,"PHASE1":115,"PHASE2":117,"PHASE3":119,"PHASE4":121,"NA":135},{"trials":114,"activeCount":54},[],{"trials":116,"activeCount":54},[],{"trials":118,"activeCount":54},[],{"trials":120,"activeCount":54},[],{"trials":122,"activeCount":54},[123],{"nctId":124,"briefTitle":125,"status":126,"phases":127,"primaryCompletion":128,"completion":129,"start":130,"enrollment":131,"conditions":132,"interventions":134},"NCT06901518","The Effect of Galcanezumab-gnlm on Post-Traumatic, Migrainous Headaches","COMPLETED",[47],"2024-06-30","2024-11-30","2020-08-10",25,[133],"Post-Traumatic Headache",[111],{"trials":136,"activeCount":54},[],{"intervention":138,"totalTrials":83,"cells":139},"Experimental dosing of labetalol",{"EARLY_PHASE1":140,"PHASE1":142,"PHASE2":144,"PHASE3":146,"PHASE4":148,"NA":161},{"trials":141,"activeCount":54},[],{"trials":143,"activeCount":54},[],{"trials":145,"activeCount":54},[],{"trials":147,"activeCount":54},[],{"trials":149,"activeCount":54},[150],{"nctId":151,"briefTitle":152,"status":153,"phases":154,"primaryCompletion":155,"completion":155,"start":156,"enrollment":157,"conditions":158,"interventions":160},"NCT03877692","Acute Control of Chronic Hypertension","TERMINATED",[47],"2020-07-20","2019-02-18",10,[26,159],"Chronic Hypertension in Obstetric Context",[138],{"trials":162,"activeCount":54},[],{"intervention":164,"totalTrials":83,"cells":165},"Liposomal bupivacaine",{"EARLY_PHASE1":166,"PHASE1":168,"PHASE2":170,"PHASE3":172,"PHASE4":174,"NA":188},{"trials":167,"activeCount":54},[],{"trials":169,"activeCount":54},[],{"trials":171,"activeCount":54},[],{"trials":173,"activeCount":54},[],{"trials":175,"activeCount":54},[176],{"nctId":177,"briefTitle":178,"status":179,"phases":180,"primaryCompletion":181,"completion":182,"start":183,"enrollment":54,"conditions":184,"interventions":186},"NCT02624856","Liposomal Bupivacaine Versus Standard Bupivacaine Plus Dexamethasone in Quadriceps Sparing Femoral Nerve Block and Wound Infiltration for Total Knee Arthroplasty","WITHDRAWN",[47],"2017-11","2020-01-01","2015-11",[185,28],"Osteoarthritis",[164,187],"Bupivacaine plus dexamethasone",{"trials":189,"activeCount":54},[],{"intervention":187,"totalTrials":83,"cells":191},{"EARLY_PHASE1":192,"PHASE1":194,"PHASE2":196,"PHASE3":198,"PHASE4":200,"NA":206},{"trials":193,"activeCount":54},[],{"trials":195,"activeCount":54},[],{"trials":197,"activeCount":54},[],{"trials":199,"activeCount":54},[],{"trials":201,"activeCount":54},[202],{"nctId":177,"briefTitle":178,"status":179,"phases":203,"primaryCompletion":181,"completion":182,"start":183,"enrollment":54,"conditions":204,"interventions":205},[47],[185,28],[164,187],{"trials":207,"activeCount":54},[],{"intervention":209,"totalTrials":83,"cells":210},"Gabapentin",{"EARLY_PHASE1":211,"PHASE1":213,"PHASE2":215,"PHASE3":217,"PHASE4":219,"NA":231},{"trials":212,"activeCount":54},[],{"trials":214,"activeCount":54},[],{"trials":216,"activeCount":54},[],{"trials":218,"activeCount":54},[],{"trials":220,"activeCount":54},[221],{"nctId":222,"briefTitle":223,"status":153,"phases":224,"primaryCompletion":225,"completion":225,"start":226,"enrollment":227,"conditions":228,"interventions":229},"NCT05024825","Effect of Gabapentin on Postoperative Opioid Analgesic Use and Pain in Adolescents Undergoing Tonsillectomy",[47],"2021-05-19","2017-08-04",17,[28],[209,230],"hydrocodone, acetaminophen and ibuprofen",{"trials":232,"activeCount":54},[],{"intervention":230,"totalTrials":83,"cells":234},{"EARLY_PHASE1":235,"PHASE1":237,"PHASE2":239,"PHASE3":241,"PHASE4":243,"NA":249},{"trials":236,"activeCount":54},[],{"trials":238,"activeCount":54},[],{"trials":240,"activeCount":54},[],{"trials":242,"activeCount":54},[],{"trials":244,"activeCount":54},[245],{"nctId":222,"briefTitle":223,"status":153,"phases":246,"primaryCompletion":225,"completion":225,"start":226,"enrollment":227,"conditions":247,"interventions":248},[47],[28],[209,230],{"trials":250,"activeCount":54},[],{"intervention":252,"totalTrials":83,"cells":253},"Ziconotide 100 MCG(microgram)\u002FML Intrathecal Solution",{"EARLY_PHASE1":254,"PHASE1":256,"PHASE2":258,"PHASE3":260,"PHASE4":262,"NA":274},{"trials":255,"activeCount":54},[],{"trials":257,"activeCount":54},[],{"trials":259,"activeCount":54},[],{"trials":261,"activeCount":54},[],{"trials":263,"activeCount":54},[264],{"nctId":265,"briefTitle":266,"status":126,"phases":267,"primaryCompletion":268,"completion":269,"start":270,"enrollment":271,"conditions":272,"interventions":273},"NCT03321955","Ziconotide as First-Line IDT",[47],"2020-08-30","2020-12-30","2016-11-03",13,[20],[252],{"trials":275,"activeCount":54},[],{"intervention":277,"totalTrials":83,"cells":278},"Oxycodone\u002Facetaminophen",{"EARLY_PHASE1":279,"PHASE1":281,"PHASE2":283,"PHASE3":285,"PHASE4":287,"NA":299},{"trials":280,"activeCount":54},[],{"trials":282,"activeCount":54},[],{"trials":284,"activeCount":54},[],{"trials":286,"activeCount":54},[],{"trials":288,"activeCount":54},[289],{"nctId":290,"briefTitle":291,"status":179,"phases":292,"primaryCompletion":293,"completion":293,"start":294,"enrollment":54,"conditions":295,"interventions":297},"NCT02703610","Randomized Trial of Two Analgesics in Elderly ED Patients",[47],"2026-07-30","2024-07-01",[296],"Pain",[277,298],"Ibuprofen\u002Facetaminophen",{"trials":300,"activeCount":54},[],{"intervention":298,"totalTrials":83,"cells":302},{"EARLY_PHASE1":303,"PHASE1":305,"PHASE2":307,"PHASE3":309,"PHASE4":311,"NA":317},{"trials":304,"activeCount":54},[],{"trials":306,"activeCount":54},[],{"trials":308,"activeCount":54},[],{"trials":310,"activeCount":54},[],{"trials":312,"activeCount":54},[313],{"nctId":290,"briefTitle":291,"status":179,"phases":314,"primaryCompletion":293,"completion":293,"start":294,"enrollment":54,"conditions":315,"interventions":316},[47],[296],[277,298],{"trials":318,"activeCount":54},[],{"intervention":320,"totalTrials":83,"cells":321},"Milnacipran",{"EARLY_PHASE1":322,"PHASE1":324,"PHASE2":326,"PHASE3":328,"PHASE4":330,"NA":342},{"trials":323,"activeCount":54},[],{"trials":325,"activeCount":54},[],{"trials":327,"activeCount":54},[],{"trials":329,"activeCount":54},[],{"trials":331,"activeCount":54},[332],{"nctId":333,"briefTitle":334,"status":126,"phases":335,"primaryCompletion":336,"completion":336,"start":337,"enrollment":338,"conditions":339,"interventions":341},"NCT01125423","Study of Fibromyalgia Treated With Milnacipran",[47],"2013-01","2010-05",27,[340],"Fibromyalgia",[320],{"trials":343,"activeCount":54},[],{"intervention":345,"totalTrials":83,"cells":346},"Garlic Oil Macerate",{"EARLY_PHASE1":347,"PHASE1":349,"PHASE2":351,"PHASE3":353,"PHASE4":355,"NA":368},{"trials":348,"activeCount":54},[],{"trials":350,"activeCount":54},[],{"trials":352,"activeCount":54},[],{"trials":354,"activeCount":54},[],{"trials":356,"activeCount":54},[357],{"nctId":358,"briefTitle":359,"status":360,"phases":361,"completion":362,"start":363,"enrollment":364,"conditions":365,"interventions":367},"NCT00275405","Effect of Garlic on Inflammatory Mediators","SUSPENDED",[47],"2007-03","2006-04",34,[366],"Healthy",[345],{"trials":369,"activeCount":54},[],{"intervention":371,"totalTrials":83,"cells":372},"Experimental labetalol dose",{"EARLY_PHASE1":373,"PHASE1":375,"PHASE2":377,"PHASE3":379,"PHASE4":381,"NA":390},{"trials":374,"activeCount":54},[],{"trials":376,"activeCount":54},[],{"trials":378,"activeCount":54},[],{"trials":380,"activeCount":54},[],{"trials":382,"activeCount":54},[383],{"nctId":384,"briefTitle":385,"status":153,"phases":386,"primaryCompletion":155,"completion":155,"start":156,"enrollment":387,"conditions":388,"interventions":389},"NCT03872336","Acute Labetalol Use in Preeclampsia",[47],15,[26],[371],{"trials":391,"activeCount":54},[],{"intervention":393,"totalTrials":83,"cells":394},"Ketorolac Tromethamine",{"EARLY_PHASE1":395,"PHASE1":397,"PHASE2":399,"PHASE3":401,"PHASE4":403,"NA":416},{"trials":396,"activeCount":54},[],{"trials":398,"activeCount":54},[],{"trials":400,"activeCount":54},[],{"trials":402,"activeCount":54},[],{"trials":404,"activeCount":54},[405],{"nctId":406,"briefTitle":407,"status":153,"phases":408,"primaryCompletion":409,"completion":409,"start":410,"enrollment":411,"conditions":412,"interventions":414},"NCT03453541","Ketorolac Use in Pediatric Patients Undergoing Tonsillectomy",[47],"2022-11-01","2017-11-21",214,[413],"Analgesic Adverse Reaction",[393,415],"0.9% Normal Saline",{"trials":417,"activeCount":54},[],{"intervention":415,"totalTrials":83,"cells":419},{"EARLY_PHASE1":420,"PHASE1":422,"PHASE2":424,"PHASE3":426,"PHASE4":428,"NA":434},{"trials":421,"activeCount":54},[],{"trials":423,"activeCount":54},[],{"trials":425,"activeCount":54},[],{"trials":427,"activeCount":54},[],{"trials":429,"activeCount":54},[430],{"nctId":406,"briefTitle":407,"status":153,"phases":431,"primaryCompletion":409,"completion":409,"start":410,"enrollment":411,"conditions":432,"interventions":433},[47],[413],[393,415],{"trials":435,"activeCount":54},[],{"intervention":437,"totalTrials":83,"cells":438},"Botulinum toxin pyloroplasty",{"EARLY_PHASE1":439,"PHASE1":441,"PHASE2":443,"PHASE3":445,"PHASE4":447,"NA":461},{"trials":440,"activeCount":54},[],{"trials":442,"activeCount":54},[],{"trials":444,"activeCount":54},[],{"trials":446,"activeCount":54},[],{"trials":448,"activeCount":54},[449],{"nctId":450,"briefTitle":451,"status":126,"phases":452,"primaryCompletion":453,"completion":453,"start":454,"enrollment":455,"conditions":456,"interventions":459},"NCT03701919","Botulinum Toxin Pyloroplasty to Reduce Postoperative Nausea and Vomiting After Sleeve Gastrectomy",[47],"2022-11-11","2019-01-07",84,[457,458],"Bariatric Surgery","Postoperative Nausea and Vomiting",[437,460],"Normal saline pyloric",{"trials":462,"activeCount":54},[],{"intervention":460,"totalTrials":83,"cells":464},{"EARLY_PHASE1":465,"PHASE1":467,"PHASE2":469,"PHASE3":471,"PHASE4":473,"NA":479},{"trials":466,"activeCount":54},[],{"trials":468,"activeCount":54},[],{"trials":470,"activeCount":54},[],{"trials":472,"activeCount":54},[],{"trials":474,"activeCount":54},[475],{"nctId":450,"briefTitle":451,"status":126,"phases":476,"primaryCompletion":453,"completion":453,"start":454,"enrollment":455,"conditions":477,"interventions":478},[47],[457,458],[437,460],{"trials":480,"activeCount":54},[],{"intervention":482,"totalTrials":83,"cells":483},"remifentanil",{"EARLY_PHASE1":484,"PHASE1":486,"PHASE2":488,"PHASE3":490,"PHASE4":492,"NA":505},{"trials":485,"activeCount":54},[],{"trials":487,"activeCount":54},[],{"trials":489,"activeCount":54},[],{"trials":491,"activeCount":54},[],{"trials":493,"activeCount":54},[494],{"nctId":495,"briefTitle":496,"status":153,"phases":497,"primaryCompletion":498,"completion":499,"start":500,"enrollment":501,"conditions":502,"interventions":504},"NCT02164734","Surfactant Via Endotracheal Tube vs. Laryngeal Mask Airway (LMA) in Preterm Neonates With Respiratory Distress Syndrome",[47],"2020-05-20","2020-12-31","2014-06",93,[503],"Respiratory Distress Syndrome, Newborn",[482],{"trials":506,"activeCount":54},[],{"intervention":508,"totalTrials":83,"cells":509},"standard dose amoxicillin\u002Fclavulanate",{"EARLY_PHASE1":510,"PHASE1":512,"PHASE2":514,"PHASE3":516,"PHASE4":518,"NA":531},{"trials":511,"activeCount":54},[],{"trials":513,"activeCount":54},[],{"trials":515,"activeCount":54},[],{"trials":517,"activeCount":54},[],{"trials":519,"activeCount":54},[520],{"nctId":521,"briefTitle":522,"status":126,"phases":523,"primaryCompletion":524,"completion":524,"start":525,"enrollment":526,"conditions":527,"interventions":529},"NCT02340000","Clinical Trial of the Treatment of Acute Sinusitis With Standard-dose Versus High-dose Amoxicillin\u002FClavulanate",[47],"2017-02-27","2014-11-18",315,[528],"Sinusitis",[508,530],"high dose amoxicillin\u002Fclavulanate",{"trials":532,"activeCount":54},[],{"intervention":530,"totalTrials":83,"cells":534},{"EARLY_PHASE1":535,"PHASE1":537,"PHASE2":539,"PHASE3":541,"PHASE4":543,"NA":549},{"trials":536,"activeCount":54},[],{"trials":538,"activeCount":54},[],{"trials":540,"activeCount":54},[],{"trials":542,"activeCount":54},[],{"trials":544,"activeCount":54},[545],{"nctId":521,"briefTitle":522,"status":126,"phases":546,"primaryCompletion":524,"completion":524,"start":525,"enrollment":526,"conditions":547,"interventions":548},[47],[528],[508,530],{"trials":550,"activeCount":54},[],{"intervention":552,"totalTrials":83,"cells":553},"hydrocodone\u002Facetaminophen",{"EARLY_PHASE1":554,"PHASE1":556,"PHASE2":558,"PHASE3":560,"PHASE4":562,"NA":574},{"trials":555,"activeCount":54},[],{"trials":557,"activeCount":54},[],{"trials":559,"activeCount":54},[],{"trials":561,"activeCount":54},[],{"trials":563,"activeCount":54},[564],{"nctId":565,"briefTitle":566,"status":126,"phases":567,"primaryCompletion":336,"completion":336,"start":568,"enrollment":569,"conditions":570,"interventions":572},"NCT00574015","The Comparison of Supraperiosteal Nerve Block With Opiate Analgesia in Alleviating the Pain of Toothache",[47],"2007-12",18,[571],"Toothache",[552,573],"bupivacaine",{"trials":575,"activeCount":54},[],{"intervention":573,"totalTrials":83,"cells":577},{"EARLY_PHASE1":578,"PHASE1":580,"PHASE2":582,"PHASE3":584,"PHASE4":586,"NA":592},{"trials":579,"activeCount":54},[],{"trials":581,"activeCount":54},[],{"trials":583,"activeCount":54},[],{"trials":585,"activeCount":54},[],{"trials":587,"activeCount":54},[588],{"nctId":565,"briefTitle":566,"status":126,"phases":589,"primaryCompletion":336,"completion":336,"start":568,"enrollment":569,"conditions":590,"interventions":591},[47],[571],[552,573],{"trials":593,"activeCount":54},[],{"intervention":595,"totalTrials":83,"cells":596},"Ketamine",{"EARLY_PHASE1":597,"PHASE1":599,"PHASE2":601,"PHASE3":603,"PHASE4":605,"NA":618},{"trials":598,"activeCount":54},[],{"trials":600,"activeCount":54},[],{"trials":602,"activeCount":54},[],{"trials":604,"activeCount":54},[],{"trials":606,"activeCount":54},[607],{"nctId":608,"briefTitle":609,"status":126,"phases":610,"primaryCompletion":611,"completion":611,"start":612,"enrollment":613,"conditions":614,"interventions":617},"NCT02651324","Efficacy of Ketamine for Improvement in Postoperative Pain Control After Spinal Fusion for Idiopathic Scoliosis",[47],"2017-12","2013-05",50,[615,616],"Idiopathic Scoliosis","Post-operative Pain",[595],{"trials":619,"activeCount":54},[],{"intervention":621,"totalTrials":83,"cells":622},"ACTHAR Gel",{"EARLY_PHASE1":623,"PHASE1":625,"PHASE2":627,"PHASE3":629,"PHASE4":641,"NA":643},{"trials":624,"activeCount":54},[],{"trials":626,"activeCount":54},[],{"trials":628,"activeCount":54},[],{"trials":630,"activeCount":54},[631],{"nctId":632,"briefTitle":633,"status":66,"phases":634,"primaryCompletion":635,"completion":183,"start":636,"enrollment":157,"conditions":637,"interventions":640},"NCT02155803","ACTHAR GEL for Sarcoidosis-Associated Calcium Dysregulation: An Open-label Pilot Study",[45,46],"2015-06","2015-02",[638,639],"Sarcoidosis","Hypercalcemia Due to Sarcoidosis",[621],{"trials":642,"activeCount":54},[],{"trials":644,"activeCount":54},[],{"intervention":646,"totalTrials":83,"cells":647},"ACTHAR Gel 40 units twice weekly",{"EARLY_PHASE1":648,"PHASE1":650,"PHASE2":652,"PHASE3":654,"PHASE4":667,"NA":669},{"trials":649,"activeCount":54},[],{"trials":651,"activeCount":54},[],{"trials":653,"activeCount":54},[],{"trials":655,"activeCount":54},[656],{"nctId":657,"briefTitle":658,"status":66,"phases":659,"primaryCompletion":660,"completion":661,"start":662,"enrollment":157,"conditions":663,"interventions":665},"NCT02348905","ACTHAR Gel for Cutaneous Sarcoidosis: An Open Label Trial",[45,46],"2015-07","2016-01","2015-03",[638,664],"Cutaneous Sarcoidosis",[646,666],"ACTHAR Gel 80 units twice weekly.",{"trials":668,"activeCount":54},[],{"trials":670,"activeCount":54},[],{"intervention":666,"totalTrials":83,"cells":672},{"EARLY_PHASE1":673,"PHASE1":675,"PHASE2":677,"PHASE3":679,"PHASE4":685,"NA":687},{"trials":674,"activeCount":54},[],{"trials":676,"activeCount":54},[],{"trials":678,"activeCount":54},[],{"trials":680,"activeCount":54},[681],{"nctId":657,"briefTitle":658,"status":66,"phases":682,"primaryCompletion":660,"completion":661,"start":662,"enrollment":157,"conditions":683,"interventions":684},[45,46],[638,664],[646,666],{"trials":686,"activeCount":54},[],{"trials":688,"activeCount":54},[],{"intervention":690,"totalTrials":83,"cells":691},"Efficacy of ceftaroline",{"EARLY_PHASE1":692,"PHASE1":694,"PHASE2":696,"PHASE3":698,"PHASE4":710,"NA":712},{"trials":693,"activeCount":54},[],{"trials":695,"activeCount":54},[],{"trials":697,"activeCount":54},[],{"trials":699,"activeCount":54},[700],{"nctId":701,"briefTitle":702,"status":126,"phases":703,"primaryCompletion":704,"completion":704,"start":705,"enrollment":706,"conditions":707,"interventions":709},"NCT01605864","Use of Ceftaroline in Hospitalized Patients With Community Acquired Pneumonia",[46],"2013-03","2012-05",12,[708],"Community Acquired Bacterial Pneumonia",[690],{"trials":711,"activeCount":54},[],{"trials":713,"activeCount":54},[],{"intervention":715,"totalTrials":83,"cells":716},"Lidocaine 5% patches",{"EARLY_PHASE1":717,"PHASE1":719,"PHASE2":721,"PHASE3":723,"PHASE4":735,"NA":737},{"trials":718,"activeCount":54},[],{"trials":720,"activeCount":54},[],{"trials":722,"activeCount":54},[],{"trials":724,"activeCount":54},[725],{"nctId":726,"briefTitle":727,"status":126,"phases":728,"primaryCompletion":729,"completion":729,"start":730,"enrollment":731,"conditions":732,"interventions":734},"NCT01086150","Use of Topical Lidocaine to Reduce Pain in Patients With Diabetic Neuropathy",[45,46],"2015-10","2009-10",51,[733],"Diabetic Peripheral Neuropathy",[715],{"trials":736,"activeCount":54},[],{"trials":738,"activeCount":54},[],{"intervention":740,"totalTrials":83,"cells":741},"Atorvastatin 40mg",{"EARLY_PHASE1":742,"PHASE1":744,"PHASE2":746,"PHASE3":756,"PHASE4":758,"NA":760},{"trials":743,"activeCount":54},[],{"trials":745,"activeCount":54},[],{"trials":747,"activeCount":54},[748],{"nctId":749,"briefTitle":750,"status":179,"phases":751,"primaryCompletion":69,"completion":69,"start":752,"enrollment":54,"conditions":753,"interventions":755},"NCT03188978","High-intensity Atorvastatin for Arteriovenous Fistula Failure (HAFF): A Feasibility Pilot Study",[44,45],"2018-11-01",[754],"Primary Arteriovenous Fistula Failure",[740],{"trials":757,"activeCount":54},[],{"trials":759,"activeCount":54},[],{"trials":761,"activeCount":54},[],{"intervention":763,"totalTrials":83,"cells":764},"Anastrozole 1mg",{"EARLY_PHASE1":765,"PHASE1":767,"PHASE2":769,"PHASE3":782,"PHASE4":784,"NA":786},{"trials":766,"activeCount":54},[],{"trials":768,"activeCount":54},[],{"trials":770,"activeCount":54},[771],{"nctId":772,"briefTitle":773,"status":126,"phases":774,"primaryCompletion":775,"completion":775,"start":776,"enrollment":777,"conditions":778,"interventions":780},"NCT03933618","Anastrazole and Clomiphene to Evaluate Hypogonadal Symptoms and Erectile Function",[45],"2017-03-08","2015-04-02",24,[779],"Hypogonadism, Male",[763,781],"Clomiphene Citrate 25mg",{"trials":783,"activeCount":54},[],{"trials":785,"activeCount":54},[],{"trials":787,"activeCount":54},[],{"intervention":781,"totalTrials":83,"cells":789},{"EARLY_PHASE1":790,"PHASE1":792,"PHASE2":794,"PHASE3":800,"PHASE4":802,"NA":804},{"trials":791,"activeCount":54},[],{"trials":793,"activeCount":54},[],{"trials":795,"activeCount":54},[796],{"nctId":772,"briefTitle":773,"status":126,"phases":797,"primaryCompletion":775,"completion":775,"start":776,"enrollment":777,"conditions":798,"interventions":799},[45],[779],[763,781],{"trials":801,"activeCount":54},[],{"trials":803,"activeCount":54},[],{"trials":805,"activeCount":54},[],{"intervention":807,"totalTrials":83,"cells":808},"Decadron",{"EARLY_PHASE1":809,"PHASE1":811,"PHASE2":813,"PHASE3":826,"PHASE4":828,"NA":830},{"trials":810,"activeCount":54},[],{"trials":812,"activeCount":54},[],{"trials":814,"activeCount":54},[815],{"nctId":816,"briefTitle":817,"status":66,"phases":818,"primaryCompletion":819,"completion":819,"start":820,"enrollment":821,"conditions":822,"interventions":824},"NCT01065961","Randomized Controlled Trials of the Effects of Decadron on Swallowing, Airway, and Arthrodesis",[44,45],"2016-11","2008-11",200,[823],"Swallowing",[807,825],"Saline",{"trials":827,"activeCount":54},[],{"trials":829,"activeCount":54},[],{"trials":831,"activeCount":54},[],{"intervention":825,"totalTrials":83,"cells":833},{"EARLY_PHASE1":834,"PHASE1":836,"PHASE2":838,"PHASE3":844,"PHASE4":846,"NA":848},{"trials":835,"activeCount":54},[],{"trials":837,"activeCount":54},[],{"trials":839,"activeCount":54},[840],{"nctId":816,"briefTitle":817,"status":66,"phases":841,"primaryCompletion":819,"completion":819,"start":820,"enrollment":821,"conditions":842,"interventions":843},[44,45],[823],[807,825],{"trials":845,"activeCount":54},[],{"trials":847,"activeCount":54},[],{"trials":849,"activeCount":54},[],{"intervention":851,"totalTrials":83,"cells":852},"fluorouracil",{"EARLY_PHASE1":853,"PHASE1":855,"PHASE2":867,"PHASE3":869,"PHASE4":871,"NA":873},{"trials":854,"activeCount":54},[],{"trials":856,"activeCount":54},[857],{"nctId":858,"briefTitle":859,"status":126,"phases":860,"completion":861,"start":862,"conditions":863,"interventions":865},"NCT00004257","Oxaliplatin and Fluorouracil Plus Radiation Therapy in Treating Patients With Primary Esophageal or Stomach Cancer",[44],"2004-01","2000-01",[864],"Esophageal Cancer",[851,866],"oxaliplatin",{"trials":868,"activeCount":54},[],{"trials":870,"activeCount":54},[],{"trials":872,"activeCount":54},[],{"trials":874,"activeCount":54},[],{"intervention":866,"totalTrials":83,"cells":876},{"EARLY_PHASE1":877,"PHASE1":879,"PHASE2":885,"PHASE3":887,"PHASE4":889,"NA":891},{"trials":878,"activeCount":54},[],{"trials":880,"activeCount":54},[881],{"nctId":858,"briefTitle":859,"status":126,"phases":882,"completion":861,"start":862,"conditions":883,"interventions":884},[44],[864],[851,866],{"trials":886,"activeCount":54},[],{"trials":888,"activeCount":54},[],{"trials":890,"activeCount":54},[],{"trials":892,"activeCount":54},[],{"intervention":894,"totalTrials":11,"cells":895},"Ibuprofen",{"EARLY_PHASE1":896,"PHASE1":898,"PHASE2":900,"PHASE3":902,"PHASE4":904,"NA":916},{"trials":897,"activeCount":54},[],{"trials":899,"activeCount":54},[],{"trials":901,"activeCount":54},[],{"trials":903,"activeCount":54},[],{"trials":905,"activeCount":54},[906],{"nctId":907,"briefTitle":908,"status":66,"phases":909,"primaryCompletion":910,"completion":910,"start":911,"enrollment":912,"conditions":913,"interventions":915},"NCT01681667","Tablet vs. Liquid Suspension Ibuprofen in the Relief of Pain",[47],"2015-05","2013-09",100,[914],"Pharyngitis",[894],{"trials":917,"activeCount":54},[918],{"nctId":919,"briefTitle":920,"status":126,"phases":921,"primaryCompletion":68,"completion":68,"start":922,"enrollment":157,"conditions":923,"interventions":924},"NCT03008876","IV Acetaminophen and Patent Ductus Arteriosus",[48],"2017-01-01",[15],[925,894],"Acetaminophen",{"intervention":925,"totalTrials":11,"cells":927},{"EARLY_PHASE1":928,"PHASE1":930,"PHASE2":932,"PHASE3":934,"PHASE4":936,"NA":938},{"trials":929,"activeCount":54},[],{"trials":931,"activeCount":54},[],{"trials":933,"activeCount":54},[],{"trials":935,"activeCount":54},[],{"trials":937,"activeCount":54},[],{"trials":939,"activeCount":54},[940,947],{"nctId":941,"briefTitle":942,"status":126,"phases":943,"primaryCompletion":68,"completion":68,"start":944,"enrollment":8,"conditions":945,"interventions":946},"NCT03289390","Treatment of a PDA With Acetaminophen in Preterm Neonates: Exploring Various Indications",[],"2017-08-01",[15],[925],{"nctId":919,"briefTitle":920,"status":126,"phases":948,"primaryCompletion":68,"completion":68,"start":922,"enrollment":157,"conditions":949,"interventions":950},[48],[15],[925,894],{"intervention":952,"totalTrials":83,"cells":953},"Duloxetine",{"EARLY_PHASE1":954,"PHASE1":956,"PHASE2":958,"PHASE3":960,"PHASE4":962,"NA":964},{"trials":955,"activeCount":54},[],{"trials":957,"activeCount":54},[],{"trials":959,"activeCount":54},[],{"trials":961,"activeCount":54},[],{"trials":963,"activeCount":54},[],{"trials":965,"activeCount":54},[966],{"nctId":967,"briefTitle":968,"status":126,"phases":969,"primaryCompletion":970,"completion":970,"start":971,"enrollment":131,"conditions":972,"interventions":973},"NCT01127490","Study to Assess Mechanisms in Peripheral Tissue Innervation for Fibromyalgia",[48],"2015-09-09","2010-05-05",[340],[952],{"intervention":975,"totalTrials":83,"cells":976},"Benzyl Peroxide",{"EARLY_PHASE1":977,"PHASE1":979,"PHASE2":981,"PHASE3":983,"PHASE4":985,"NA":987},{"trials":978,"activeCount":54},[],{"trials":980,"activeCount":54},[],{"trials":982,"activeCount":54},[],{"trials":984,"activeCount":54},[],{"trials":986,"activeCount":54},[],{"trials":988,"activeCount":54},[989],{"nctId":990,"briefTitle":991,"status":126,"phases":992,"primaryCompletion":993,"completion":994,"start":995,"enrollment":996,"conditions":997,"interventions":999},"NCT04112407","The Effect of Pretreatment for Propionibacterium Acnes on Surgical Site Burden in Shoulder Arthroplasty",[48],"2022-12-01","2022-12-31","2019-01-10",120,[998],"Shoulder Arthroplasty",[975],{"intervention":1001,"totalTrials":83,"cells":1002},"Simethicone",{"EARLY_PHASE1":1003,"PHASE1":1005,"PHASE2":1007,"PHASE3":1009,"PHASE4":1011,"NA":1013},{"trials":1004,"activeCount":54},[],{"trials":1006,"activeCount":54},[],{"trials":1008,"activeCount":54},[],{"trials":1010,"activeCount":54},[],{"trials":1012,"activeCount":54},[],{"trials":1014,"activeCount":54},[1015],{"nctId":1016,"briefTitle":1017,"status":66,"phases":1018,"primaryCompletion":1019,"completion":1020,"start":1021,"enrollment":1022,"conditions":1023,"interventions":1025},"NCT03166605","Ingestion of Simethicone After Capsule Ingestion and Its Impact on Quality of Video Capsule Endoscopy- a Pilot Study",[48],"2019-03","2019-06","2017-05-03",36,[1024],"Video Capsule Endoscopy",[1001]]